Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Insiders Buying OPKO Health And 2 Other Penny Stocks

Published 30/01/2024, 14:04
© Reuters.  Insiders Buying OPKO Health And 2 Other Penny Stocks

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

The Dow Jones index closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

OPKO Health

  • The Trade: OPKO Health, Inc. (NASDAQ: OPK) Director Richard Krasno acquired a total of 30,000 shares an average price of $0.99. To acquire these shares, it cost around $29,838.
  • What’s Happening: OPKO Health recently priced private offering of $200 million convertible senior notes due 2029.
  • What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.
Butler National
  • The Trade: Butler National Corporation (OTC: BUKS) 10% owner Joseph Patrick Daly acquired a total of 900 shares at at an average price of $0.73. To acquire these shares, it cost around $657.
  • What’s Happening: On Nov. 1, Butler National's subsidiary, Avcon Industries, Inc., obtained FAA approval of the Avcon nose extension and the Avcon extra-large "Whale Pod" modifications in the King Air Model B300 Airplanes.
  • What Butler National Does: Butler National Corp is engaged in designing, manufacturing and selling, installing, repairing, modifying, overhauling, servicing and distributing a broad portfolio of aerostructures, aircraft components, avionics, accessories, subassemblies, and systems.

RENN Fund

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • The Trade: RENN Fund, Inc. (NYSE: RCG) President and CEO Murray Stahl acquired a total of 56 shares at an average price of $1.62. The insider spent around $90.72 to buy those shares.
  • What’s Happening: RENN Fund fell around 10% over the past six months.
  • What RENN Fund Does: RENN Fund Inc is active in the financial services domain. It is a closed-end management investment company formed with the objective of providing long-term capital appreciation by investing substantially in privately placed convertible and equity securities of emerging growth companies traded on the United States securities exchanges.

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.